card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

H5N1 Pandemic preparedness: Building a comprehensive immunological toolbox

H5N1 Pandemic preparedness: Building a comprehensive immunological toolbox
Home / Insights / H5N1 Pandemic preparedness: Building a comprehensive immunological toolbox

By: Martine Boyer, Patrick Rheault, Vitalie Samoil

 

Presented at: PEGS, the Protein Engineering Summit, May 12-16, 2025, Boston, MA

 

H1N1, a highly pathogenic avian influenza subtype, has caused severe poultry outbreaks and sporadic human transmission with mortality rates over 50%. As the virus evolves, the need for effective preparedness becomes urgent. Immunological tools play a central role, offering insights into disease mechanisms, advancing vaccines, enhancing diagnostics, and guiding therapeutics. This poster highlights key innovations to build a comprehensive toolbox for H5N1 pandemic preparedness.

 

Complete the form below to access this scientific poster.